Widespread use of antiretroviral agents and increasing occurrence of
human immunodeficiency virus (HIV) strains resistant to these drugs have given
rise to a number of important issues. Some of these concerns are distinct
from the obvious question of the relationship between drug resistance and
treatment failure and have potentially widespread public health implications.
The relevant issues include but are not limited to the following:(1) frequency
with which drug-resistant virus may be transmitted via sexual, intravenous,
or mother-to-child routes; (2) ability of drug-resistant variants to be transmitted,
a question that relates, in part, to the relative fitness of such strains;
(3) effectiveness of antiviral therapy in diminishing viral burden in both
blood and genital secretions, and whether this may be compromised in persons
harboring resistant virus; and (4) importance of patient adherence to antiviral
therapy and its relationship to sustained reduction in viral load to minimize
the appearance in and transmission of drug-resistant virus from both blood
and genital secretions. Thus, prevention of both development of HIV drug resistance
as well as transmission of drug-resistant variants is a central issue of public
health importance. Unless this topic is appropriately addressed, the likelihood
is that drug-resistant variants of HIV, if able to successfully replicate,
will sustain the epidemic and limit the effectiveness of antiviral therapy.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 333
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
For example, a trial of intravenous immunoglobulin in advanced human immunodeficiency infection...
The Rational Clinical Examination
Evidence Summary and Review 3
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.